Jeffrey F. DiModica's Biography

Early Education and Career

Jeffrey F. DiModica began his higher education at Boston University, where he earned a Bachelor of Science in Business Administration and Management in 1989. He furthered his education at Dartmouth College - The Tuck School of Business, obtaining a Master of Business Administration (MBA) in 1993¹.

Early Career in Finance

After completing his MBA, DiModica started his career in the Merchant and Investment Banking Group of the Commercial Real Estate Department at Chemical Bank from 1989 to 1991. He then moved to Merrill Lynch, where he sold derivative and MBS products from 1993 to 2001^{2 3}.

Royal Bank of Scotland

In 2001, DiModica joined the Royal Bank of Scotland (RBS), where he would spend over a decade. He served as Head of MBS/ABS/CMBS sales and strategy for the Americas and managed a team of 40 professionals. His responsibilities included the distribution of mortgage-backed securities, asset-backed securities, and commercial mortgage-backed securities to institutional clients².

Starwood Property Trust

DiModica's significant career shift occurred in 2014 when he was appointed President of Starwood Property Trust, a leading diversified finance company with a core focus on the real estate and infrastructure sectors. He had been an external director of the company since its inception in 2009 until taking on the executive role^{2 3}. As President, he leads and serves as a member of the investment committee of each of the company's business lines, which collectively manage $28 billion in assets³.

Industry Recognition and Volunteering

Jeffrey F. DiModica has been recognized as one of the "50 Most Important Figures of Commercial Real Estate Finance" by the Commercial Observer for several years, ranking in the top 10 for the past five years⁴. He is also a member of the Young Presidents Organization (YPO) and serves on the Miami Advisory Board of the Posse Foundation. Additionally, DiModica was the founding president of MitoAction.org, a support, education, and advocacy group for families affected by Mitochondrial Disease^{3 4}.

Citations